The article presents views of professionals in field of Ophtthalmology including OSN Chief Medical Editor Richard L. Lindstrom and CathyG. Cohen, American Academy of Ophthalmology to possible in Affordable Care Act (ACA) and Food and Drug Administration (FDA) under U.S. President Donald Trump.